This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Stayner L, Welch LS, Lemen R. The worldwide pandemic of asbestos-related diseases. Annu Rev Public Health 2013; 34: 205-16. doi: 10.1146/annurev-publhealth-031811-124704StaynerLWelchLSLemenRThe worldwide pandemic of asbestos-related diseasesAnnu Rev Public Health2013342051610.1146/annurev-publhealth-031811-124704Open DOISearch in Google Scholar
Vainio H. Epidemics of asbestos-related diseases - something old, something new. Scand J Work Environ Health 2015; 41: 1-4. doi: 10.5271/sjweh.3471VainioHEpidemics of asbestos-related diseases - something old, something newScand J Work Environ Health2015411410.5271/sjweh.3471Open DOISearch in Google Scholar
Kamp DW, Graceffa P, Pryor WA, Weitzman SA. The role of free radicals in asbestos-induced diseases. Free Radic Biol Med 1992; 12: 293-315. doi: 10.1016/0891-5849(92)90117-yKampDWGraceffaPPryorWAWeitzmanSAThe role of free radicals in asbestos-induced diseasesFree Radic Biol Med19921229331510.1016/0891-5849(92)90117-yOpen DOISearch in Google Scholar
Kinnula VL. Oxidant and antioxidant mechanisms of lung disease caused by asbestos fibres. Eur Respir J 1999; 14: 706-16. doi: 10.1034/j.1399-3003.1999.14c35.xKinnulaVLOxidant and antioxidant mechanisms of lung disease caused by asbestos fibresEur Respir J1999147061610.1034/j.1399-3003.1999.14c35.xOpen DOISearch in Google Scholar
Solbes E, Harper RW. Biological responses to asbestos inhalation and pathogenesis of asbestos-related benign and malignant disease. J Investig Med 2018; 66: 721-7. doi: 10.1136/jim-2017-000628SolbesEHarperRWBiological responses to asbestos inhalation and pathogenesis of asbestos-related benign and malignant diseaseJ Investig Med201866721710.1136/jim-2017-000628Open DOISearch in Google Scholar
Nichenametla SN, Muscat JE, Liao JG, Lazarus P, Richie JP, Jr. A functional trinucleotide repeat polymorphism in the 5’-untranslated region of the glutathione biosynthetic gene GCLC is associated with increased risk for lung and aerodigestive tract cancers. Mol Carcinog 2013; 52: 791-9. doi: 10.1002/mc.21923NichenametlaSNMuscatJELiaoJGLazarusPRichieJPJrA functional trinucleotide repeat polymorphism in the 5’-untranslated region of the glutathione biosynthetic gene GCLC is associated with increased risk for lung and aerodigestive tract cancersMol Carcinog201352791910.1002/mc.21923Open DOISearch in Google Scholar
Zhang H, Liu H, Zhou L, Yuen J, Forman HJ. Temporal changes in glutathione biosynthesis during the lipopolysaccharide-induced inflammatory response of THP-1 macrophages. Free Radic Biol Med 2017; 113: 304-10. doi: 10.1016/j.freeradbiomed.2017.10.010ZhangHLiuHZhouLYuenJFormanHJTemporal changes in glutathione biosynthesis during the lipopolysaccharide-induced inflammatory response of THP-1 macrophagesFree Radic Biol Med20171133041010.1016/j.freeradbiomed.2017.10.010Open DOISearch in Google Scholar
Ketterer B. A bird’s eye view of the glutathione transferase field. Chem Biol Interact 2001; 138: 27-42. doi: 10.1016/s0009-2797(01)00277-0KettererBA bird’s eye view of the glutathione transferase fieldChem Biol Interact2001138274210.1016/s0009-2797(01)00277-0Open DOISearch in Google Scholar
Strange RC, Spiteri MA, Ramachandran S, Fryer AA. Glutathione-S-transferase family of enzymes. Mutat Res 2001; 482: 21-6. doi: 10.1016/s0027-5107(01)00206-8StrangeRCSpiteriMARamachandranSFryerAAGlutathione-S-transferase family of enzymesMutat Res200148221610.1016/s0027-5107(01)00206-8Open DOISearch in Google Scholar
Chen Y, Shertzer HG, Schneider SN, Nebert DW, Dalton TP. Glutamate cysteine ligase catalysis: dependence on ATP and modifier subunit for regulation of tissue glutathione levels. J Biol Chem 2005; 280: 33766-74. doi: 10.1074/jbc.M504604200ChenYShertzerHGSchneiderSNNebertDWDaltonTPGlutamate cysteine ligase catalysis: dependence on ATP and modifier subunit for regulation of tissue glutathione levelsJ Biol Chem2005280337667410.1074/jbc.M50460420016081425Open DOISearch in Google Scholar
Traverso N, Ricciarelli R, Nitti M, Marengo B, Furfaro AL, Pronzato MA, et al. Role of glutathione in cancer progression and chemoresistance. Oxid Med Cell Longev 2013; 2013: 972913. doi: 10.1155/2013/972913TraversoNRicciarelliRNittiMMarengoBFurfaroALPronzatoMAet alRole of glutathione in cancer progression and chemoresistanceOxid Med Cell Longev2013201397291310.1155/2013/972913Open DOISearch in Google Scholar
Zmorzynski S, Swiderska-Kolacz G, Koczkodaj D, Filip AA. Significance of polymorphisms and expression of enzyme-encoding genes related to glutathione in hematopoietic cancers and solid tumors. Biomed Res Int 2015; 2015: 853573. doi: 10.1155/2015/853573ZmorzynskiSSwiderska-KolaczGKoczkodajDFilipAASignificance of polymorphisms and expression of enzyme-encoding genes related to glutathione in hematopoietic cancers and solid tumorsBiomed Res Int2015201585357310.1155/2015/853573Open DOISearch in Google Scholar
Flanagan JU, Smythe ML. Sigma-class glutathione transferases. Drug Metab Rev 2011; 43: 194-214. doi: 10.3109/03602532.2011.560157FlanaganJUSmytheMLSigma-class glutathione transferasesDrug Metab Rev20114319421410.3109/03602532.2011.560157Open DOISearch in Google Scholar
Tan XL, Moslehi R, Han W, Spivack SD. Haplotype-tagging single nucleotide polymorphisms in the GSTP1 gene promoter and susceptibility to lung cancer. Cancer Detect Prev 2009; 32: 403-15. doi: 10.1016/j.cdp.2009.02.004TanXLMoslehiRHanWSpivackSDHaplotype-tagging single nucleotide polymorphisms in the GSTP1 gene promoter and susceptibility to lung cancerCancer Detect Prev2009324031510.1016/j.cdp.2009.02.004Open DOISearch in Google Scholar
Hayes JD, Strange RC. Glutathione S-transferase polymorphisms and their biological consequences. Pharmacology 2000; 61: 154-66. doi: 10.1159/000028396HayesJDStrangeRCGlutathione S-transferase polymorphisms and their biological consequencesPharmacology2000611546610.1159/000028396Open DOISearch in Google Scholar
Hirvonen A, Saarikoski ST, Linnainmaa K, Koskinen K, Husgafvel-Pursiainen K, Mattson K, et al. Glutathione S-transferase and N-acetyltransferase genotypes and asbestos-associated pulmonary disorders. J Natl Cancer Inst 1996; 88: 1853-6. doi: 10.1093/jnci/88.24.1853HirvonenASaarikoskiSTLinnainmaaKKoskinenKHusgafvel-PursiainenKMattsonKet alGlutathione S-transferase and N-acetyltransferase genotypes and asbestos-associated pulmonary disordersJ Natl Cancer Inst1996881853610.1093/jnci/88.24.1853Open DOISearch in Google Scholar
Koide S, Kugiyama K, Sugiyama S, Nakamura S, Fukushima H, Honda O, et al. Association of polymorphism in glutamate-cysteine ligase catalytic subunit gene with coronary vasomotor dysfunction and myocardial infarction. J Am Coll Cardiol 2003; 41: 539-45. doi: 10.1016/s0735-1097(02)02866-8KoideSKugiyamaKSugiyamaSNakamuraSFukushimaHHondaOet alAssociation of polymorphism in glutamate-cysteine ligase catalytic subunit gene with coronary vasomotor dysfunction and myocardial infarctionJ Am Coll Cardiol2003415394510.1016/s0735-1097(02)02866-8Open DOISearch in Google Scholar
Yuniastuti A, Susanti R, Mustikaningtyas D. Polymorphism of glutamate-cysteine ligase subunit catalytic (GCLC) gene in pulmonary tuberculosis patients. Pak J Biol Sci 2017; 20: 397-402. doi: 10.3923/pjbs.2017.397.402YuniastutiASusantiRMustikaningtyasDPolymorphism of glutamate-cysteine ligase subunit catalytic (GCLC) gene in pulmonary tuberculosis patientsPak J Biol Sci20172039740210.3923/pjbs.2017.397.40229023060Open DOISearch in Google Scholar
Skvortsova L, Perfelyeva A, Khussainova E, Mansharipova A, Forman HJ, Djansugurova L. Association of GCLM -588C/T and GCLC -129T/C promoter polymorphisms of genes coding the subunits of glutamate cysteine ligase with ischemic heart disease development in Kazakhstan population. Dis Markers 2017; 2017: 4209257. doi: 10.1155/2017/4209257SkvortsovaLPerfelyevaAKhussainovaEMansharipovaAFormanHJDjansugurovaLAssociation of GCLM -588C/T and GCLC -129T/C promoter polymorphisms of genes coding the subunits of glutamate cysteine ligase with ischemic heart disease development in Kazakhstan populationDis Markers20172017420925710.1155/2017/4209257551675128757675Open DOISearch in Google Scholar
Li J, Yin F, Lin Y, Gao M, Wang L, Liu S, et al. Genetic susceptibility analysis of GCLC rs17883901 polymorphism to preeclampsia in Chinese Han women. Gynecol Endocrinol 2020; 36: 781-5. doi: 10.1080/09513590.2020.1725970LiJYinFLinYGaoMWangLLiuSet alGenetic susceptibility analysis of GCLC rs17883901 polymorphism to preeclampsia in Chinese Han womenGynecol Endocrinol202036781510.1080/09513590.2020.172597032054366Open DOISearch in Google Scholar
Vieira SM, Monteiro MB, Marques T, Luna AM, Fortes MA, Nery M, et al. Association of genetic variants in the promoter region of genes encoding p22phox (CYBA) and glutamate cysteine ligase catalytic subunit (GCLC) and renal disease in patients with type 1 diabetes mellitus. BMC Med Genet 2011; 12: 129. doi: 10.1186/1471-2350-12-129VieiraSMMonteiroMBMarquesTLunaAMFortesMANeryMet alAssociation of genetic variants in the promoter region of genes encoding p22phox (CYBA) and glutamate cysteine ligase catalytic subunit (GCLC) and renal disease in patients with type 1 diabetes mellitusBMC Med Genet20111212910.1186/1471-2350-12-129320641921962117Open DOISearch in Google Scholar
Hayes JD, Flanagan JU, Jowsey IR. Glutathione transferases. Annu Rev Pharmacol Toxicol 2005; 45: 51-88. doi: 10.1146/annurev.pharm-tox.45.120403.095857HayesJDFlanaganJUJowseyIRGlutathione transferasesAnnu Rev Pharmacol Toxicol200545518810.1146/annurev.pharm-tox.45.120403.095857Open DOISearch in Google Scholar
Ali-Osman F, Akande O, Antoun G, Mao JX, Buolamwini J. Molecular cloning, characterization, and expression in Escherichia coli of full-length cDNAs of three human glutathione S-transferase Pi gene variants. Evidence for differential catalytic activity of the encoded proteins. J Biol Chem 1997; 272: 10004-12. doi: 10.1074/jbc.272.15.10004Ali-OsmanFAkandeOAntounGMaoJXBuolamwiniJMolecular cloning, characterization, and expression in Escherichia coli of full-length cDNAs of three human glutathione S-transferase Pi gene variants. Evidence for differential catalytic activity of the encoded proteinsJ Biol Chem1997272100041210.1074/jbc.272.15.100049092542Open DOISearch in Google Scholar
Hirvonen A, Pelin K, Tammilehto L, Karjalainen A, Mattson K, Linnainmaa K. Inherited GSTM1 and NAT2 defects as concurrent risk modifiers in asbestos-related human malignant mesothelioma. Cancer Res 1995; 55: 2981-3. PMID: 7606714HirvonenAPelinKTammilehtoLKarjalainenAMattsonKLinnainmaaKInherited GSTM1 and NAT2 defects as concurrent risk modifiers in asbestos-related human malignant mesotheliomaCancer Res19955529813PMID: 7606714Search in Google Scholar
Landi S, Gemignani F, Neri M, Barale R, Bonassi S, Bottari F, et al. Polymorphisms of glutathione-S-transferase M1 and manganese superoxide dismutase are associated with the risk of malignant pleural mesothelioma. Int J Cancer 2007; 120: 2739-43. doi: 10.1002/ijc.22590LandiSGemignaniFNeriMBaraleRBonassiSBottariFet alPolymorphisms of glutathione-S-transferase M1 and manganese superoxide dismutase are associated with the risk of malignant pleural mesotheliomaInt J Cancer200712027394310.1002/ijc.2259017290392Open DOISearch in Google Scholar
Kukkonen MK, Hamalainen S, Kaleva S, Vehmas T, Huuskonen MS, Oksa P, et al. Genetic susceptibility to asbestos-related fibrotic pleuropulmonary changes. Eur Respir J 2011; 38: 672-8. doi: 10.1183/09031936.00049810KukkonenMKHamalainenSKalevaSVehmasTHuuskonenMSOksaPet alGenetic susceptibility to asbestos-related fibrotic pleuropulmonary changesEur Respir J201138672810.1183/09031936.0004981020847076Open DOISearch in Google Scholar
Franko A, Dodic-Fikfak M, Arneric N, Dolzan V. Glutathione S-transferases GSTM1 and GSTT1 polymorphisms and asbestosis. J Occup Environ Med 2007; 49: 667-71. doi: 10.1097/JOM.0b013e318065b855FrankoADodic-FikfakMArnericNDolzanVGlutathione S-transferases GSTM1 and GSTT1 polymorphisms and asbestosisJ Occup Environ Med2007496677110.1097/JOM.0b013e318065b85517563610Open DOISearch in Google Scholar
Franko A, Dolzan V, Arneric N, Dodic-Fikfak M. The influence of genetic polymorphisms of GSTP1 on the development of asbestosis. J Occup Environ Med 2008; 50: 7-12. doi: 10.1097/JOM.0b013e31815cbab5FrankoADolzanVArnericNDodic-FikfakMThe influence of genetic polymorphisms of GSTP1 on the development of asbestosisJ Occup Environ Med20085071210.1097/JOM.0b013e31815cbab518188076Open DOISearch in Google Scholar
Chen CL, Liu Q, Relling MV. Simultaneous characterization of glutathione S-transferase M1 and T1 polymorphisms by polymerase chain reaction in American whites and blacks. Pharmacogenetics 1996; 6: 187-91. doi: 10.1097/00008571-199604000-00005ChenCLLiuQRellingMVSimultaneous characterization of glutathione S-transferase M1 and T1 polymorphisms by polymerase chain reaction in American whites and blacksPharmacogenetics199661879110.1097/00008571-199604000-000059156696Open DOISearch in Google Scholar
Jakobsson K, Rannug A, Alexandrie AK, Rylander L, Albin M, Hagmar L. Genetic polymorphism for glutathione-S-transferase mu in asbestos cement workers. Occup Environ Med 1994; 51: 812-6. doi: 10.1136/oem.51.12.812JakobssonKRannugAAlexandrieAKRylanderLAlbinMHagmarLGenetic polymorphism for glutathione-S-transferase mu in asbestos cement workersOccup Environ Med199451812610.1136/oem.51.12.81211281217849864Open DOISearch in Google Scholar
Jamrozik E, de Klerk N, Musk AW. Asbestos-related disease. Intern Med J 2011; 41: 372-80. doi: 10.1111/j.1445-5994.2011.02451.xJamrozikEdeKlerk NMuskAWAsbestos-related diseaseIntern Med J2011413728010.1111/j.1445-5994.2011.02451.x21309996Open DOISearch in Google Scholar
Frank AL, Joshi TK. The global spread of asbestos. Ann Glob Health 2014; 80: 257-62. doi: 10.1016/j.aogh.2014.09.016FrankALJoshiTKThe global spread of asbestosAnn Glob Health2014802576210.1016/j.aogh.2014.09.01625459326Open DOISearch in Google Scholar
Lacourt A, Lévêque E, Guichard E, Gilg Soit Ilg A, Sylvestre MP, Leffondré K. Dose-time-response association between occupational asbestos exposure and pleural mesothelioma. Occup Environ Med 2017; 74: 691-7. doi: 10.1136/oemed-2016-104133LacourtALévêqueEGuichardEGilgSoit Ilg ASylvestreMPLeffondréKDose-time-response association between occupational asbestos exposure and pleural mesotheliomaOccup Environ Med201774691710.1136/oemed-2016-10413328501798Open DOISearch in Google Scholar
Ulvestad B, Kjærheim K, Martinsen JI, Damberg G, Wannag A, Mowe G, et al. Cancer incidence among workers in the asbestos-cement producing industry in Norway. Scand J Work Environ Health 2002; 28: 411-7. doi: 10.5271/sjweh.693UlvestadBKjærheimKMartinsenJIDambergGWannagAMoweGet alCancer incidence among workers in the asbestos-cement producing industry in NorwayScand J Work Environ Health200228411710.5271/sjweh.69312539801Open DOISearch in Google Scholar
Nishimura Y, Kumagai-Takei N, Matsuzaki H, Lee S, Maeda M, Kishimoto T, et al. Functional alteration of natural killer cells and cytotoxic T lymphocytes upon asbestos exposure and in malignant mesothelioma patients. Biomed Res Int 2015; 2015: 238431. doi: 10.1155/2015/238431NishimuraYKumagai-TakeiNMatsuzakiHLeeSMaedaMKishimotoTet alFunctional alteration of natural killer cells and cytotoxic T lymphocytes upon asbestos exposure and in malignant mesothelioma patientsBiomed Res Int2015201523843110.1155/2015/238431448648426161391Open DOISearch in Google Scholar
Rosner D, Markowitz G, Chowkwanyun M. “Nondetected”: the politics of measurement of asbestos in talc, 1971-1976. Am J Public Health 2019; 109: 969-74. doi: 10.2105/ajph.2019.305085RosnerDMarkowitzGChowkwanyunM.“Nondetected”: the politics of measurement of asbestos in talc, 1971-1976Am J Public Health20191099697410.2105/ajph.2019.305085660344531095409Open DOISearch in Google Scholar
Pairon JC, Laurent F, Rinaldo M, Clin B, Andujar P, Ameille J, et al. Pleural plaques and the risk of pleural mesothelioma. J Natl Cancer Inst 2013; 105: 293-301. doi: 10.1093/jnci/djs513PaironJCLaurentFRinaldoMClinBAndujarPAmeilleJet alPleural plaques and the risk of pleural mesotheliomaJ Natl Cancer Inst201310529330110.1093/jnci/djs51323355760Open DOISearch in Google Scholar
Maxim LD, Niebo R, Utell MJ. Are pleural plaques an appropriate endpoint for risk analyses? Inhal Toxicol 2015; 27: 321-34. doi: 10.3109/08958378.2015.1051640MaximLDNieboRUtellMJAre pleural plaques an appropriate endpoint for risk analyses?Inhal Toxicol2015273213410.3109/08958378.2015.105164026075933Open DOISearch in Google Scholar
